ANNEX IV
Reporting model for the implementation of the approved preventive vaccination plans referred to in article 6(2)
General information | ||||||
|---|---|---|---|---|---|---|
Country | Zoo | Vaccine | Route(specify if different in different species) | Weight — Dose regime used(Actual/estimated/average weight of species) | Vaccine interval | Interval from last vaccination to post-vaccination blood collection |
HI serum antibody titre | |||||||
|---|---|---|---|---|---|---|---|
English name/local name | Latin name | Taxonomic Order | Individual identification | VaccineDose (ml) | Pre-vacc | Post-1st vacc | Post-2nd vacc |
Adverse Individual effects | Mortality | ||
|---|---|---|---|
Local | general | Direct(catching/handling) | Delayed(specify cause of death) |
Information required from the Laboratory | ||||
|---|---|---|---|---|
Virus strain of vaccine | Antigens (virus strains) used in HI test | Cut-off or end-titre point used as a measure of vaccine efficacy | Reference serum used | (reference to)Methodology |